UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No. 1)*

VASOGEN INC.

(Name of Issuer)

Common shares, no par value

(Title of Class of Securities)

92232F202

(CUSIP Number)

December 31, 2008

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:

[X] Rule 13d-1(b)

[_] Rule 13d-1(c)

[_] Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


-----------------------------------------------------------------------------
CUSIP NO. 92232F202 13G Page 2 of 8 Pages
-----------------------------------------------------------------------------
(1) NAMES OF REPORTING PERSONS.
 I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only).

 Renaissance Technologies LLC 26-0385758
-----------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS):
 (a) [_]
 (b) [_]
-----------------------------------------------------------------------------
(3) SEC USE ONLY

-----------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION

 Delaware
-----------------------------------------------------------------------------
 (5) SOLE VOTING POWER

 NUMBER OF SHARES 1,536,480
 BENEFICIALLY OWNED _____________________________
 BY EACH REPORTING
 PERSON WITH: (6) SHARED VOTING POWER

 0
 _____________________________

 (7) SOLE DISPOSITIVE POWER

 1,536,480
 _____________________________

 (8) SHARED DISPOSITIVE POWER

 0
 ______________________________

(9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 1,536,480
------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
 (SEE INSTRUCTIONS)
 [_]
------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 6.86%
------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 IA

 Page 2 of 8 pages
=============================================================================
-----------------------------------------------------------------------------
 CUSIP NO. 92232F202 13G Page 3 of 8 Pages
-----------------------------------------------------------------------------
 (1) NAMES OF REPORTING PERSONS.
 I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).

 James H. Simons
-----------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
 (a) [_]
 (b) [_]
-----------------------------------------------------------------------------
(3) SEC USE ONLY

-----------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION

 United States
-----------------------------------------------------------------------------
 (5) SOLE VOTING POWER

 NUMBER OF SHARES 1,536,480
 BENEFICIALLY OWNED _____________________________
 BY EACH REPORTING
 PERSON WITH: (6) SHARED VOTING POWER

 0
 _____________________________

 (7) SOLE DISPOSITIVE POWER

 1,536,480
 _____________________________
 (8) SHARED DISPOSITIVE POWER

 0
 _____________________________


(9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 1,536,480
-----------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
 (SEE INSTRUCTIONS)
 [_]
-----------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 6.86 %
-----------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 IN

 Page 3 of 8 pages
=============================================================================
-----------------------------------------------------------------------------
 CUSIP NO. 92232F202 13G Page 4 of 8 Pages
-----------------------------------------------------------------------------
Item 1.

 (a) Name of Issuer

 VASOGEN INC.

 (b) Address of Issuer's Principal Executive Offices.

 2505 Meadowvale Boulevard, Mississauga, Ontario, L5N 5S2, Canada

Item 2.

 (a) Name of Person Filing:

 This Schedule 13G is being filed by Renaissance Technologies LLC
 ("RTC") and James H. Simons ("Simons").

 (b) Address of Principal Business Office or, if none, Residence.

 The principal business address of the reporting persons is:

 800 Third Avenue
 New York, New York 10022

 (c) Citizenship.

 Dr. Simons is a United States citizen and
 RTC is a Delaware limited liability company.

 (d) Title of Class of Securities.

 Common shares, no par value

 (e) CUSIP Number.

 92232F202

 Page 4 of 8 pages
=============================================================================
Item 3. If this statement is filed pursuant to Rule 13d-1(b) or 13-d-2(b)
 or (c),check whether the person filing is a:

(a) [_] Broker or dealer registered under section 15 of the Act.
(b) [_] Bank as defined in section 3(a)(6) of the Act.
(c) [_] Insurance Company as defined in section 3(a)(19) of the Act.
(d) [_] Investment Company registered under section 8 of the Investment
 Company Act.
(e) [x] Investment Adviser in accordance with Sec.240.13d-1(b)(1)(ii)(E).
(f) [_] Employee Benefit Plan or Endowment Fund in accordance with
 Sec. 240.13d-1(b)(1)(ii)(F).
(g) [_] Parent holding company, in accordance with Sec.240.13d-1(b)(1)(ii)(G).
(h) [_] A savings associations as defined in Section 3(b) of the Federal
 Deposit Insurance Act.
(i) [_] A church plan that is excluded from the definition of an investment
 company under section 3(c)(14) of the Investment Company Act of 1940.
(j) [_] Group, in accordance with Sec.240.13d-1(b)(1)(ii)(J).


Item 4. Ownership.

 (a) Amount beneficially owned.

 RTC: 1,536,480 shares
 Simons: 1,536,480 shares, comprising the shares beneficially owned
 by RTC, because of Dr. Simons' position as control
 person of RTC.

 (b) Percent of Class.

 RTC: 6.86 %
 Simons: 6.86 %

 (c) Number of shares as to which the person has:

 (i) sole power to vote or to direct the vote:

 RTC: 1,536,480
 Simons: 1,536,480

 (ii) Shared power to vote or to direct the vote: 0


 (iii) sole power to dispose or to direct the disposition of:

 RTC: 1,536,480
 Simons: 1,536,480
 (iv) Shared power to dispose or to direct the disposition of:

 RTC: 0
 Simons: 0

 Page 5 of 8 pages
=============================================================================
Item 5. Ownership of Five Percent or Less of a Class.

 If this statement is being filed to report the fact that as of the
 date hereof the reporting person has ceased to be the beneficial
 owner of more than five percent of the class of securities,
 check the following: [_]

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

 Certain funds and accounts managed by RTC have the right to receive
 dividends and proceeds from the sale of the securities which are
 the subject of this report.
 RIEF Trading LLC holds of record more than 5% of such securities.

Item 7. Identification and Classification of the Subsidiary Which Acquired
 the Security Being Reported on by the Parent Holding Company.

 Not applicable

Item 8. Identification and Classification of Members of the Group.

 Not applicable

Item 9. Notice of Dissolution of a Group.

 Not applicable

 Page 6 of 8 pages
=============================================================================
Item 10. Certification

By signing below I certify that, to the best of my knowledge and belief,
the securities referred to above were acquired and are held in the ordinary
course of business and not acquired and are not held for the purpose of or
with the effect of changing or influencing the control of the issuer of the
securities and were not acquired and are not held in connection with or as
a participant in any transaction having that purpose or effect.


 SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete
and correct.

Date: February 12, 2009




 James H. Simons



 Renaissance Technologies LLC


 By: Mark Silber
 Executive Vice President


Attention: Intentional misstatements or omissions of fact constitute
Federal criminal violations (See 18 U.S.C. 1001).



 Page 7 of 8 Pages
==============================================================================

 EXHIBIT 99.1

 AGREEMENT REGARDING JOINT FILING

 UNDER RULE 13D-1(K) OF THE EXCHANGE ACT


In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934,
as amended, each of the undersigned agrees to the filing on behalf of each
of a Statement on Schedule 13G, and all amendments thereto, with respect to
the shares of Common shares, no par value of
 VASOGEN INC..


Date: February 12, 2009



 James H. Simons



 Renaissance Technologies LLC


 By: Mark Silber
 Executive Vice President










 Page 8 of 8 Pages

Vasogen (NASDAQ:VSGN)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Vasogen Charts.
Vasogen (NASDAQ:VSGN)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Vasogen Charts.